Inequality kills. But we can stop the killing.
So argues a gripping new book from an activist physician who’s helped divine the keys to long and healthy life.
Why this isn’t the time for a public option or Medicare for some
What is the real purpose of a public option or lowering the age of Medicare when neither is an effective nor a lasting solution?
#Flint: An update and a reminder that it has been 1,196 days since Flint...
Flint’s water problems started in April 2014 when the city switched its water source from the city of Detroit to the Flint River.
Tribes mount organized responses to COVID-19, in contrast to state and federal governments
The story of inequity is imbued with dispossession of lands and is met with organizing from the inside: two crucial points for untangling and responding to COVID-19.
Intelligence thieves: How toxic pollutants are robbing communities of color
In her new book, author and ethicist Harriet Washington unearths one of the most overlooked aspects of environmental racism.
Sanders introduces bill aimed to combat corporate polluters and clean up toxic drinking water
“It is not a radical idea to demand that when people in the world’s richest country turn on their taps, the water they drink is free of toxic chemicals.”
How cities can combat the dangerous combination of extreme heat and COVID
The compounding threats of heat and isolation have been laid bare this summer thanks to COVID-19.
Make drug price cuts visible: Biden-era law delivers savings for 15 Medicare drugs as...
A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs.
Medicare for all: It’s a matter of life and death
Just 17 percent of people support the current Senate health care bill.
New documents show how drug companies targeted doctors to increase opioid prescriptions
A trove of recently released documents offers the public an unvarnished look inside those relationships from the perspective of drug companies themselves.